To identify the most promising candidates for downstream validation, we developed a prioritization scoring system based on three key criteria: (1) evidence of a direct interaction with MMP12, (2) annotation of transcriptional regulation by MMP12, and (3) overlap with cancer-associated gene sets (lung cancer, apoptosis, migration, expressed in A549). This evidence concerns the gene MMP12 and cancer.